Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Qualigen Therapeutics Cash Flow from Operating Activities 2015-2023 | QLGN

Qualigen Therapeutics cash flow from operating activities from 2015 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  
Qualigen Therapeutics Annual Cash Flow Ops
(Millions of US $)
2023 $-10
2022 $-13
2021 $-15
2020 $
2019 $-15
2018 $-13
2017 $-7
2016 $-15
2015 $-6
2014 $-1
2013 $
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.005B
Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.935B 31.69
Chugai Pharmaceutical (CHGCY) Japan $48.297B 21.59
Takeda Pharmaceutical (TAK) Japan $40.953B 8.29
Merck (MKGAF) Germany $23.081B 22.38
Astellas Pharma (ALPMY) Japan $17.463B 27.57
Sandoz Group AG (SDZNY) Switzerland $14.891B 0.00
Neurocrine Biosciences (NBIX) United States $13.548B 37.08
Shionogi (SGIOY) Japan $13.012B 11.31
United Therapeutics (UTHR) United States $11.875B 12.66
Catalent (CTLT) United States $9.697B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.437B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.572B 7.22
Revolution Medicines (RVMD) United States $6.222B 0.00
Orion OYJ (ORINY) Finland $5.637B 23.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Ionis Pharmaceuticals (IONS) United States $5.320B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.742B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.613B 0.00
Corcept Therapeutics (CORT) United States $3.283B 29.75
Arrowhead Pharmaceuticals (ARWR) United States $2.840B 0.00
Dyne Therapeutics (DYN) United States $2.716B 0.00
PTC Therapeutics (PTCT) United States $2.687B 0.00
Indivior (INDV) United States $2.487B 11.79
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.093B 11.90
Summit Therapeutics (SMMT) United States $2.060B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.039B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.876B 18.25
Fusion Pharmaceuticals (FUSN) Canada $1.821B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.708B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.595B 23.98
Ardelyx (ARDX) United States $1.538B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.498B 0.00
Soleno Therapeutics (SLNO) United States $1.433B 0.00
Xencor (XNCR) United States $1.430B 0.00
Pacira BioSciences (PCRX) United States $1.362B 12.95
BioCryst Pharmaceuticals (BCRX) United States $1.269B 0.00
4D Molecular Therapeutics (FDMT) United States $1.239B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.130B 0.00
Collegium Pharmaceutical (COLL) United States $1.086B 6.50
Cassava Sciences (SAVA) United States $1.021B 0.00
Enliven Therapeutics (ELVN) United States $1.003B 0.00
Cronos Group (CRON) Canada $0.978B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.944B 14.71
Ocular Therapeutix (OCUL) United States $0.909B 0.00
ProKidney (PROK) United States $0.908B 0.00
USANA Health Sciences (USNA) United States $0.888B 14.52
ARS Pharmaceuticals (SPRY) United States $0.855B 0.00
Relay Therapeutics (RLAY) United States $0.822B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.808B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Sage Therapeutics (SAGE) United States $0.654B 0.00
Lyell Immunopharma (LYEL) United States $0.653B 0.00
Silence Therapeutics (SLN) United Kingdom $0.645B 0.00
Harrow (HROW) United States $0.631B 0.00
Savara (SVRA) United States $0.573B 0.00
Exscientia (EXAI) United Kingdom $0.565B 0.00
Bioventus (BVS) United States $0.539B 20.64
OmniAb (OABI) United States $0.535B 0.00
Siga Technologies (SIGA) United States $0.526B 6.73
Lexeo Therapeutics (LXEO) United States $0.500B 0.00
Heron Therapeutics (HRTX) United States $0.493B 0.00
Altimmune (ALT) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.465B 0.00
Korro Bio (KRRO) United States $0.464B 0.00
Larimar Therapeutics (LRMR) United States $0.451B 0.00
Verve Therapeutics (VERV) United States $0.427B 0.00
Esperion Therapeutics (ESPR) United States $0.411B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.403B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.358B 0.00
Tourmaline Bio (TRML) United States $0.349B 0.00
Organogenesis (ORGO) United States $0.341B 64.25
Fractyl Health (GUTS) United States $0.324B 0.00
Nanobiotix S.A (NBTX) France $0.315B 0.00
Xeris Biopharma Holdings (XERS) United States $0.286B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Century Therapeutics (IPSC) United States $0.269B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nektar Therapeutics (NKTR) United States $0.254B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.252B 0.00
CytoDyn (CYDY) United States $0.241B 0.00
Metagenomi (MGX) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.227B 0.00
Pyxis Oncology (PYXS) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Eliem Therapeutics (ELYM) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.220B 0.00
Akebia Therapeutics (AKBA) United States $0.216B 0.00
Elite Pharmaceuticals (ELTP) United States $0.197B 18.40
Adherex Technologies (FENC) United States $0.195B 238.33
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Telomir Pharmaceuticals (TELO) United States $0.190B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Achieve Life Sciences (ACHV) Canada $0.183B 0.00
Prelude Therapeutics (PRLD) United States $0.182B 0.00
Profound Medical (PROF) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.164B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.161B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
VAXART, INC (VXRT) United States $0.145B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
OptiNose (OPTN) United States $0.121B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.114B 7.59
Karyopharm Therapeutics (KPTI) United States $0.113B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
Assertio Holdings (ASRT) United States $0.091B 4.14
Vivani Medical (VANI) United States $0.090B 0.00
Relmada Therapeutics (RLMD) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.083B 1.18
Journey Medical (DERM) United States $0.077B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Protara Therapeutics (TARA) United States $0.060B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Carisma Therapeutics (CARM) United States $0.054B 0.00
Inotiv (NOTV) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Gain Therapeutics (GANX) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Lipocine (LPCN) United States $0.035B 0.00
Unicycive Therapeutics (UNCY) United States $0.032B 0.00
JanOne (JAN) United States $0.028B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Talphera (TLPH) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
CERo Therapeutics Holdings (CERO) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
SHINECO (SISI) China $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 32.47